Abstract: Provided are: a dicyano N-heterocyclic compound represented by formula (I) (in the formula, R3 represents an electron-donating group, and n represents the number of repetitions of the content in brackets and is 0 or 1), the compound having exceptional heat resistance and light emission characteristics; a light-emitting material; and a light-emitting element in which the same is used.

Abstract: A compound represented by A-D-A is useful as a light. emitting material used in an organic electroluminescent device and others.

Abstract: A method for designing a protein capable of binding in an RNA base selective manner or RNA base sequence specific manner is provided.

Abstract: Provided are a membrane electrode assembly, including a solid electrolyte layer, an anode layer provided on one side of the solid electrolyte layer, and a cathode layer provided on the other side of the solid electrolyte layer, the anode layer being stacked on the solid electrolyte layer to be pressed thereagainst, the anode layer including a porous anode member having electrical conductivity; and a method for manufacturing the same.

Abstract: A method for controlling the kinetics of a cultured cell includes: a culture step of culturing a cell adhered to the surface of a base material including titanium oxide having an anatase structure on the surface; an irradiation step of irradiating the surface with light in a wavelength range in which the titanium oxide exhibits photocatalytic activity during culture of the cell; and a control step of controlling the kinetics of the cell by controlling the irradiation amount of the light to the surface. The wavelength range may be 400 nm or less.

Abstract: The present invention provides a compound capable of being used as an active ingredient of an anti-cancer agent. To provide an anti-cancer agent with few side effects, an object of the present invention is to provide a compound capable of selectively inhibiting the target, i.e., DOCK1, or a salt thereof. The pyridinone compound of the present invention is represented by Formula (1): wherein R1 and R2 are the same or different, and each represents C1-6 alkyl; and R3 is a group represented by, for example, Formula (3) below: wherein R5 in the group represented by Formula (3) is hydrogen.

Abstract: A fixing stand to which an endoscope body and treatment instruments can be easily attached in an easy-to-operate manner and which facilitates increase or decrease in the number of such items is provided. A fixing stand includes legs and a fixing stand body erected on the legs, the fixing stand allowing at least one or more of an endoscope body of an endoscope and an operation input portion of a treatment instrument for use in a surgery to be attached to the fixing stand in a detachable manner. The endoscope body and the operation input portion are attached to fixtures which are disposed side by side substantially horizontally to the direction in which the fixing stand is erected. The fixtures are detachably attached to a fixing base which extends substantially horizontally to the fixing stand body. A hanger component is further attached to the fixing base.

Abstract: A fixing device for an endoscope that allows easy detachment of the endoscope from an endoscope holder even with the endoscope kept inserted in a body cavity is provided. A fixing device for fixing an endoscope capable of observing an operative site in a body cavity using an endoscope having an insertion portion to be inserted into the body cavity and an endoscope body attached at an end of the insertion portion. The fixing device includes a holder body which is attached to a fixing stand placed on a floor and holds the endoscope body in a rotatable manner. The holder body includes a detaching mechanism that allows the endoscope body to be detached from the holder body while keeping the insertion portion inserted in the body cavity.

Abstract: A compound represented by formula (I) or formula (II): in formula (I), R3 represents an electron donating group, R4 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L3 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L4 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L3 and L4 may bond together to form a ring with the carbon atoms to which they are bonded, in formula (II), R5 represents an electron donating group, R6 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L5 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L6 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group.

Abstract: With the present invention, glycoalbumin and hemoglobin A1c are measured in a blood sample, and the incidence of or the existence or non-existence of a development risk of Alzheimer's disease can then be determined based on the calculated glycoalbumin/hemoglobin A1c ratio. Compounds for treating or preventing Alzheimer's disease can also be selected using this glycoalbumin/hemoglobin A1c ratio.

Abstract: An object is to provide a method for manufacturing a calcium carbonate block of no less than 0.1 cm in diameter and thickness, not including any impurities, and able to be employed as a raw material of an artificial bone that requires biosafety: the method includes: (a) shaping a calcium hydroxide block; (b) being exposed to carbon dioxide; and (c) immersing in a carbonate ion containing solution.

Abstract: A system for producing an ion concentration gradient and a temperature-responsive electrolyte material which are utilizable, for example, for efficiently converting heat energy that has been discarded into reusable energy or for efficiently recovering an acid gas, such as carbon dioxide is provided. A temperature-responsive electrolyte is used to produce an ion concentration gradient by means of a temperature gradient. The temperature-responsive electrolyte is used in the state of an aqueous solution and also in the state of a solid phase.

Abstract: A mononuclear iron bivalent complex having iron-silicon bonds, which is represented by formula (1), can exhibit an excellent catalytic activity in at least one reaction selected from three reactions, i.e., a hydrosilylation reaction, a hydrogenation reaction and a reaction for reducing a carbonyl compound.

Abstract: A compound represented by formula (I) or formula (1I): in formula (I), R3 represents an electron donating group, R4 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L3 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L4 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L3 and L4 may bond together to form a ring with the carbon atoms to which they are bonded, in formula (II), R5 represents an electron donating group, R6 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L5 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L6 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group.

Abstract: One aspect is contemplated for providing a device having a liquid crystal material exhibiting a dielectric constant of 1000 or more at a temperature at which a specific liquid crystal phase is developed, and a unit configured to apply voltage to the liquid crystal material at the temperature at which the specific liquid crystal phase is developed.

Abstract: The object of the present invention is to generalize and improve DNA-binding proteins using PPR. There is provided a protein that contains one or more PPR motifs having a structure of the following formula 1, wherein one PPR motif (Mn) contained in the protein is a PPR motif having a specific combination of amino acids corresponding to a target DNA base or target DNA base sequence as the three amino acids of No. 1 A.A., No. 4 A.A., and No. “ii” (?2) A.A, and satisfies at least one selected from the group consisting of the following conditions (a) to (h): (a) No. 7 A.A. of the PPR motif (Mn) is isoleucine (I); (b) No. 9 A.A. of the PPR motif (Mn) is alanine (A); (c) No. 10 A.A. of the PPR motif (Mn) is tyrosine (Y); (d) No. 18 A.A. of the PPR motif (Mn) is lysine (K), arginine (R), or histidine (H); (e) No. 20 A.A. of the PPR motif (Mn) is glutamic acid (E), or aspartic acid (D); (f) No. 29 A.A. of the PPR motif (Mn) is glutamic acid (E), or aspartic acid (D); (g) No. 31 A.A.

Abstract: A compound represented by formula (I) or formula (II): in formula (I), R3 represents an electron donating group, R4 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L3 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L4 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L3 and L4 may bond together to form a ring with the carbon atoms to which they are bonded, in formula (II), R5 represents an electron donating group, R6 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L5 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L6 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group.

Abstract: A system for producing an ion concentration gradient and a temperature-responsive electrolyte material which are utilizable, for example, for efficiently converting heat energy that has been discarded into reusable energy or for efficiently recovering an acid gas, such as carbon dioxide is provided. A temperature-responsive electrolyte is used to produce an ion concentration gradient by means of a temperature gradient. The temperature-responsive electrolyte is used in the state of an aqueous solution and also in the state of a solid phase.

Abstract: The invention discloses a long persistent luminescence emitter which has an electron-donating molecule that is stable in the radical cation state and an electron-accepting molecule that is stable in the radical anion state and from which luminescence is observed at 10 K after photo-irradiation of the long persistent luminescence emitter stops. According to the disclosed invention, persistent luminescence can be exhibited for a long time with only organic compounds without the use of any rare-earth elements.

Abstract: An organic light-emitting device having a layer 10 containing a delayed blue fluorescent material, a layer 11 containing separately or together a green fluorescent material and a red fluorescent material, and a spacer layer 12 arranged between the layer 10 and the layer 11 can efficiently emit white color.